Article Details
Retrieved on: 2021-09-01 20:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA is evaluating data submitted by Pfizer-BioNTech in a supplemental Biologics License Application for its COVID-19 vaccine and will discuss it with ...
Article found on: www.fda.gov
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here